Pfizer, Inc. ( /ˈfaɪzər/) (NYSE: PFE) es una empresa farmacéuti... - dofaq.co
Pfizer, Inc. ( /ˈfaɪzər/) (NYSE: PFE) es una empresa farmacéuti...Pfizer, Inc. ( /ˈfaɪzər/) (NYSE: PFE) es una empresa farmacéutica estadounidense que, después de diversas fusiones llevadas a cabo con Pharmacia and Upjohn y Parke Davis, es el laboratorio líder a nivel mundial en el sector farmacéutico. La sociedad tiene su sede central en Nueva York.
Pfizer (PFE) Rises Higher Than Market: Key Facts
Experts paint tough path ahead of Alnylam's key ATTR-CM readout
EPIC-SR: The negative paxlovid data Pfizer has been sitting on
EU approves new antibiotic to tackle rise of superbugs
EC approval for Pfizer's Emblaveo in multidrug-resistant infections
European Commission Approves Pfizer's EMBLAVEO® for Patients with Multidrug-Resistant Infections and Limited ...
AbbVie Tops Doctor Ranking of Immunology Companies, Handily Beating Pfizer and J&J
Pfizer Options Trading: A Deep Dive into Market Sentiment - Pfizer (NYSE:PFE)
Pfizer Inc. (NYSE:PFE) Shares Sold by Sigma Planning Corp
Pfizer vs Moderna battle over COVID vaccine patents begins in UK
The Updated COVID Vaccines Are Here: 9 Things to Know
EC approves Pfizer's EMBLAVEO for multidrug-resistant infections
Use of the Pfizer Pentavalent Meningococcal Vaccine Among Persons Aged ≥10 Years: Recommendations of the ...
Is Pfizer Stock, At A 9-Year Low, A Sell Amid The Search For Its Big Break?
Pfizer, Moderna Set To Tee Off Over COVID-19 Vaccine Patents
Biopharma Layoff Tracker 2024: Pfizer, Sanofi, Vedanta and More Cut Staff
Pfizer’s year in review
Pfizer focuses on long COVID in latest 'Dear Scientist' video
Covid vaccine makers to clash in London over mRNA patent dispute
